The Effects Supplementation of Tart Cherry or Placebo on the Gut Microbiome, Inflammation, Oxidative Stress, and Health-related Outcomes.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ohio University
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Changes in glucose regulation assessed via insulin (mIU/L)
Study Overview
Brief Summary
There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the realm of inflammation research because sugar is known to increase the inflammatory response. The pill form of cherry supplementation has no added sugar and is naturally low in sugar (< 1g) while the juice form is higher from added sugar. Recent work indicates tart cherry consumption can change gut microbiota, which may modify inflammation. The purpose of this study is to look at the effects of taking a cherry supplement, either in capsule or juice form, on the gut microbiome, inflammation, and health-related variables such as blood pressure, glucose regulation and sleep quality.
Detailed Description
Participants will consume a tart cherry or placebo product for 30 days and attend 5 visits in the Exercise Physiology Lab at Ohio University over the 30 day period. They will self-collect a stool sample at baseline, 14 days and 30 days after supplementation. Blood samples will be taken at baseline, 7 days, 14 days, and 30 days after supplementation. Throughout the study participates will rate symptoms (stomach, head, etc.), pain and sleep quality using an online survey for which the link will be emailed. Participants will maintain normal diet and exercise routine and to track these for the duration of the study.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Basic Science
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 18 Years to 55 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •18-55 years old
- •participate in 150 minutes of exercise per week
- •non-smoker
- •have no known allergy to cherries or cherry juice
- •are not taking food supplements (turmeric/curcumin, cherry products, greens, etc.). -You must have access to the internet and be willing to record your food intake, physical activity and sleep quality/duration during the study.
Exclusion Criteria
- •not 18-55 years old.
- •have quit smoking less than one year ago.
- •have been diagnosed with a metabolic disorder such as diabetes, thyroid disorder, or high cholesterol.
- •are currently being treated for arthritis or an inflammatory condition, such as arthritis, gout, lupus or Sjogren's syndrome.
- •are currently being treated for cardiovascular disease, high blood pressure, fibromyalgia, or irritable bowel syndrome.
- •are pregnant.
- •regularly consume cherries or are allergic to cherries.
- •currently use anti-inflammatory medications.
- •have used corticosteroids in the last two months.
- •are not willing to follow a low polyphenol diet.
- •are not willing to have blood drawn on 4 occasions.
- •are not willing to provide a stool sample on 3 occasions.
- •do not have access to the internet.
Arms & Interventions
Tart cherry juice concentrate
tart cherry juice
Intervention: Tart cherry juice concentrate (Dietary Supplement)
Freeze dried tart cherry powder
tart cherry capsules
Intervention: Freeze dried tart cherry powder (Dietary Supplement)
Juice placebo
kool-aid
Intervention: Juice placebo (Dietary Supplement)
Capsule placebo
maltodextrin
Intervention: Capsule placebo (Dietary Supplement)
Outcomes
Primary Outcomes
Changes in glucose regulation assessed via insulin (mIU/L)
Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in glucose regulation assessed via glycated albumin (%).
Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in inflammation measured via erythrocyte sedimentation rate (mm/hour)
Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in sleep quantity (hours and minutes) assessed via daily survey.
Time Frame: daily for 30 days
Changes in sleep quality measured via 100mm visual analogue scale.
Time Frame: daily for 30 days
Changes in gut microbiome bacterial counts
Time Frame: baseline, 14 days, and 30 days post supplementation.
Changes in inflammation measured via tumor necrosis factor alpha (pg/mL)
Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in inflammation measured via c-reactive protein (mg/L) and uric acid (mg/dL).
Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.
Changes in glucose regulation assessed via plasma glucose (mg/dL)
Time Frame: baseline, 7 days, 14 days, and 30 days post supplementation.
Secondary Outcomes
No secondary outcomes reported
Investigators
Angela Hillman
Assistant Professor
Ohio University